Skip to main content
$137.73 -$0.07 (-5.1%)

12:00 PM EDT on 10/23/20

Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Current Price $137.73 Mkt Cap $10.8B
Open $137.41 P/E Ratio 0.00
Prev. Close $137.73 Div. (Yield) $0.00 (0.0%)
Daily Range $135.10 - $138.56 Volume 372,417
52-Wk Range $78.06 - $175.00 Avg. Daily Vol. 619,570

Caps

How do you think NASDAQ:SRPT will perform against the market?

Add Stock to CAPS Watchlist

All Players

269 Outperform
45 Underperform
 

All-Star Players

31 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SRPT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Hendrickson71 (< 20)
Submitted November 20, 2015

Good volume and positive sentiment in the market = bullish for next week!

rknapton (26.86)
Submitted August 22, 2013

Short. Biopharma. Sells more stock than has revenues. Revs declining too.

NASDAQ:SRPT VS S&P 500 (SPY)

Fools bullish on NASDAQ:SRPT are also bullish on:

Fools bearish on NASDAQ:SRPT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SRPT.

Recs

0
Member Avatar EKO01 (77.81) Submitted: 5/28/2020 3:50:26 PM : Outperform Start Price: $153.80 NASDAQ:SRPT Score: -24.69

srpt is the future of gene therapy in rare diseases. at the same time it is already strong today with very interesting pipeline and excellent management. momentum (post covid) + secular growt = sustainable growth and important gains. watch out but don't worry about volatility.

Recs

0
Member Avatar TMFEBCapital (96.98) Submitted: 1/28/2019 1:49:05 PM : Outperform Start Price: $117.60 NASDAQ:SRPT Score: -14.42

Potential to increase total addressable market from 13% to to 30% of Duchenne muscular dystrophy population by the end of 2020.

Recs

2
Member Avatar Hendrickson71 (< 20) Submitted: 11/20/2015 4:03:20 PM : Outperform Start Price: $34.96 NASDAQ:SRPT Score: +228.17

Good volume and positive sentiment in the market = bullish for next week!

Leaderboard

Find the members with the highest scoring picks in SRPT.

Score Leader

Newt805

Newt805 (60.87) Score: +3,058.93

"It's one thing to feel that you're on the right path, but it's another to think that yours is the only path." Paulo Cuelho, novelist IX X XIII XIV XL XLIII

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Newt805 60.87 6/27/2012 9/20/2019 Outperform 5Y $4.14 +3,220.05% +161.12% +3,058.93 3 Comments
ruben7086 < 20 5/10/2012 Outperform 5Y $4.80 +2,764.38% +152.99% +2,611.39 0 Comment
rustam5 74.00 4/18/2012 Outperform 5Y $5.40 +2,446.11% +148.87% +2,297.24 0 Comment
embodiedheart 23.63 4/2/2012 Outperform 5Y $6.54 +2,002.29% +143.25% +1,859.04 0 Comment
Apprentice15 91.27 2/8/2012 Outperform 3M $6.54 +2,002.29% +155.74% +1,846.56 0 Comment
blashmet < 20 2/8/2012 Outperform 5Y $6.78 +1,927.88% +156.40% +1,771.48 0 Comment
benjaeger 79.70 8/8/2011 Outperform 1Y $6.90 +1,892.61% +195.77% +1,696.84 0 Comment
Prof3215 < 20 9/16/2011 Outperform 5Y $7.50 +1,733.20% +185.09% +1,548.11 1 Comment
TheMadFlea < 20 3/22/2012 Outperform 5Y $8.16 +1,584.93% +148.44% +1,436.49 0 Comment
DudeTri 59.33 6/13/2011 Outperform 5Y $8.10 +1,597.41% +170.37% +1,427.03 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SRPT.